AxoGen, Inc. (AXGN)
NASDAQ: AXGN · IEX Real-Time Price · USD
5.83
+0.16 (2.82%)
At close: May 7, 2024, 4:00 PM
5.87
+0.04 (0.69%)
After-hours: May 7, 2024, 5:19 PM EDT
AxoGen Market Cap
AxoGen has a market cap or net worth of $254.80 million as of May 7, 2024. Its market cap has decreased by -33.70% in one year.
Market Cap
254.80M
Enterprise Value
303.24M
1-Year Change
-33.70%
Ranking
Category
Stock Price
$5.83
Market Cap Chart
Since December 1, 1998, AxoGen's market cap has increased from $12.20M to $254.80M, an increase of 1,988.51%. That is a compound annual growth rate of 12.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2024 | 247.80M | -2.06% |
| May 3, 2024 | 253.00M | -1.56% |
| May 2, 2024 | 257.00M | -9.32% |
| May 1, 2024 | 283.40M | 2.31% |
| Apr 30, 2024 | 277.00M | -3.75% |
| Apr 29, 2024 | 287.80M | 0.45% |
| Apr 26, 2024 | 286.50M | 1.70% |
| Apr 25, 2024 | 281.70M | -5.09% |
| Apr 24, 2024 | 296.80M | -1.43% |
| Apr 23, 2024 | 301.10M | 1.59% |
| Apr 22, 2024 | 296.40M | 5.56% |
| Apr 19, 2024 | 280.80M | -0.78% |
| Apr 18, 2024 | 283.00M | -5.64% |
| Apr 17, 2024 | 299.90M | -0.83% |
| Apr 16, 2024 | 302.40M | -0.43% |
| Apr 15, 2024 | 303.70M | -2.50% |
| Apr 12, 2024 | 311.50M | -1.77% |
| Apr 11, 2024 | 317.10M | -2.13% |
| Apr 10, 2024 | 324.00M | -6.60% |
| Apr 9, 2024 | 346.90M | 1.37% |
| Apr 8, 2024 | 342.20M | 1.54% |
| Apr 5, 2024 | 337.00M | 0.51% |
| Apr 4, 2024 | 335.30M | -3.70% |
| Apr 3, 2024 | 348.20M | 3.20% |
| Apr 2, 2024 | 337.40M | -1.78% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coherus BioSciences | 257.64M |
| Foghorn Therapeutics | 254.97M |
| Pyxis Oncology | 254.62M |
| Adlai Nortye | 254.08M |
| Bioventus | 253.40M |
| AngioDynamics | 251.14M |
| Fennec Pharmaceuticals | 250.13M |
| Aldeyra Therapeutics | 247.16M |